Scotland · NHS Scotland MSAN
Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for
MSAN(2024)10 · Level 2 · issued 28 Mar 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: being discontinued, stock exhausted by the end of May 2024 | Discontinued | — |
| filled disposable devices are being discontinued with remaining stock exhausted by the end of | Discontinued | — |
| filled pens remain available and can support increased demand. | Available | — |
| 3. Insulatard® Penfill® and Insulatard® vials (insulin isophane human 100units/ml) remain available | Available | — |
| but cannot support any increased demand. | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.